Clinical Trial Update: Citalopram and the Risk of Serious Adverse Events

View source ↗

Summary

A completed clinical trial update on citalopram assesses the risk of serious adverse events in adults with chronic kidney disease, including elderly outpatient …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Kidney Disease (CKD), Elderly | Status: COMPLETED